Disclosed herein are new heterocyclic compounds having structural Formula IIa
and compositions and their application as pharmaceuticals for the treatment of disease. Methods of inhibiting PAS Kinase (PASK) activity in a human or animal subject are also provided for the treatment of diseases such as diabetes mellitus.
A cobalt-catalyzed annulation of o-phenylenediamines and internal alkynes for the synthesis of quinoxalines is reported. This method provides a series of quinoxalines in good to high yields under a simple and mild reaction conditions.